No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)

Document Type

Journal Article

Publication Date

12-2020

Journal

Maturitas

Volume

142

Inclusive Pages

38-44

DOI

10.1016/j.maturitas.2020.06.021

Peer Reviewed

1

Find in your library

Share

COinS